Parkinson's Disease Market Research Reports & Industry Analysis
As the disease progresses, the shaking, or tremor, which affects the majority of PD patients may begin to interfere with daily activities. Other symptoms may include depression and other emotional changes; difficulty in swallowing, chewing, and speaking; urinary problems or constipation; skin problems; and sleep disruptions. There are currently no blood or laboratory tests that have been proven to help in diagnosing sporadic PD. Therefore the diagnosis is based on medical history and a neurological examination. The disease can be difficult to diagnose accurately.
There is no cure for PD, but a variety of medications provide dramatic relief from the symptoms. Usually, patients are given levodopa combined with carbidopa. Carbidopa delays the conversion of levodopa into dopamine until it reaches the brain. Anticholinergics may help control tremor and rigidity. Other drugs, such as bromocriptine, pramipexole, and ropinirole, mimic the role of dopamine in the brain, causing the neurons to react as they would to dopamine. An antiviral drug, amantadine, also appears to reduce symptoms.
Parkinson's Disease Industry Research & Market Reports
-
Global Parkinson’s Disease Treatment Market Size study, By Drug Class (Levodopa/carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-inhibitors, Anticholinergics, Other Drugs), By Distribution Channel (Hospital Pharmacies, Retailer Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics), and Regional Forecasts 2022-2028
... Regional Forecasts 2022-2028 Global Parkinson’s Disease Treatment Market is valued approximately USD XX Billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2028. ... Read More
-
Global Johnson Neuroectodermal Syndrome Market Size study, by Drug Class (Immunomodulators, Interferons, Decarboxylase Inhibitors, Dopamine Agonists and Others) by Disease Indication (Multiple Sclerosis, Parkinson’s Disease, Alzheimer's Disease, Spinal Muscular Atrophy (SMA) and Others), by Route of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028
... of Administration (Oral, Injection, Transdermal), by Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy) and Regional Forecasts 2022-2028 Global Johnson Neuroectodermal Syndrome Market is valued approximately USD XX billion in 2022 and is anticipated ... Read More
-
Neuromodulation Market By Technology (Internal Neuromodulation, External Neuromodulation), By Application (Chronic Pain, Urinary And Fecal Incontinence, Migraine, Failed Back Syndrome, Parkinson Disease, Epilepsy, Tremor, Depression, Other Applications), By Biomaterial (Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials), : Global Opportunity Analysis and Industry Forecast, 2020-2030
... : Global Opportunity Analysis and Industry Forecast, 2020-2030 The global neuromodulation market was valued at $2,480.2 million in 2020, and is projected to reach $4,342.5 million by 2030, registering a CAGR of 6.2% from 2021 ... Read More
-
5G in Healthcare Market Size, Share & Trends Analysis By Component, By Application, By End User, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
... 3.9 Bn by 2030 According to SPER Market Research, the 5G in healthcare market estimated to reach USD 3.9 Bn by 2030 with a CAGR of 69.8%. Technologies such as Telehealth and robotics services are ... Read More
-
Brain-computer Interface Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)
... 2026, registering a CAGR of 12.56% during the forecast period, 2021-2026. The impact of COVID-19 on the market will be significant in the short run as the global supply chain is disrupted and manufacturing facilities ... Read More
-
Global Neurorehabilitation Market Size study, by Type (Neuro-Robotic Devices, Non-Invasive Stimulators, and Brain-Computer Interfaces), by Application (Brain Stroke, Parkinson's Disease, Multiple Sclerosis, Spinal Cord Injury, Traumatic Brain Injury, Cerebral Palsy, and Others), by and End-User (Rehabilitation Centers, Hospitals, and Clinics) and Regional Forecasts 2021-2027
... (Rehabilitation Centers, Hospitals, and Clinics) and Regional Forecasts 2021-2027 Global Neurorehabilitation Market is valued at approximately USD 1097.69 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 8.3 ... Read More
-
Neurostimulation Devices Market Size By Product (Deep Brain Stimulator, Gastric Electric Stimulator, Spinal Cord Stimulator, Sacral Nerve Stimulator, Vagus Nerve Stimulator, Transcutaneous Electrical Nerve Stimulation [TENS]), By Application (Pain Management, Epilepsy, Essential Tremor, Urinary and Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027
... Fecal Incontinence, Depression, Dystonia, Gastroparesis, Parkinson's Disease), COVID-19 Impact Analysis, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2021 - 2027 The neurostimulation devices market is poised to amass significant gains by 2027 on ... Read More
-
Optogenetics Actuators and Sensors - Market Insights, Competitive Landscape and Market Forecast–2026
... and the historical and forecasted Optogenetics Actuators and Sensors market trends, globally, which comprises of North America, Europe, APAC, and RoW. The Optogenetics Actuators and Sensors market report provides an overview of Optogenetics Actuators and ... Read More
-
Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) - Market Insight, Epidemiology and Market Forecast -2032
... Disease Levodopa-Induced Dyskinesia (PD-LID) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. The Parkinson's Disease Levodopa-Induced Dyskinesia (PD-LID) market report provides current treatment practices, emerging drugs, Parkinson's ... Read More
-
Parkinson's Disease Related Dementia - Epidemiology Forecast - 2032
... EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Parkinson's Disease Related ... Read More
-
Parkinson's Disease Treatment Resistant Epilepsy - Epidemiology Forecast - 2032
... United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Parkinson's ... Read More
-
Parkinson's Disease - Epidemiology Forecast to 2032
... France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Parkinson's Disease Understanding The DelveInsight Parkinson's Disease ... Read More
-
Parkinson's disease psychosis - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Parkinson's disease psychosis Understanding The ... Read More
-
Levodopa-Induced Dyskinesia (LID) - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Levodopa-Induced Dyskinesia (LID) Understanding The ... Read More
Research Assistance
